CLINICAL TRIALS PROFILE FOR OSELTAMIVIR PHOSPHATE
✉ Email this page to a colleague
All Clinical Trials for oseltamivir phosphate
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00416962 ↗ | Safety and Pharmacokinetic Effects of Oseltamivir Alone or in Combination With Amantadine | Completed | Hoffmann-La Roche | Phase 1 | 2006-08-01 | This study is designed to assess the safety and pharmacokinetic effects of oseltamivir administration alone or in combination with amantadine in healthy volunteers. |
NCT00416962 ↗ | Safety and Pharmacokinetic Effects of Oseltamivir Alone or in Combination With Amantadine | Completed | Novartis | Phase 1 | 2006-08-01 | This study is designed to assess the safety and pharmacokinetic effects of oseltamivir administration alone or in combination with amantadine in healthy volunteers. |
NCT00453999 ↗ | Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening Influenza | Completed | BioCryst Pharmaceuticals | Phase 2 | 2007-07-01 | This study has been designed as a randomized, double-blind, controlled, study to evaluate the efficacy and safety of two once daily intravenous peramivir regimens (200 mg and 400 mg) versus oral oseltamivir phosphate (75 mg twice daily) in hospitalized subjects with acute serious or potentially life threatening influenza. Study treatments will be provided for up to 5 consecutive days. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for oseltamivir phosphate
Condition Name
Clinical Trial Locations for oseltamivir phosphate
Trials by Country
Clinical Trial Progress for oseltamivir phosphate
Clinical Trial Phase
Clinical Trial Sponsors for oseltamivir phosphate
Sponsor Name